Ekf Diagnostics Share News (EKF)

EKF gets cash payment for US inventory

(Sharecast News) - EKF Diagnostics updated the market on its strengthening cash position on Monday, having disclosed £6.7m growth in working capital in its 2021 results, "particularly as a result of additional inventory carried in the US".

IN BRIEF: EKF Diagnostics launches digital connectivity solution

EKF Diagnostics Holdings PLC - Cardiff-based diagnostics and central laboratory assay maker - Launches EKF Link, a digital connectivity solution for the management of point-of-care analysers and associated data on one centralised platform. EKF Link is a downloadable software package that allows analysers to connect to a hospital or laboratory's IT system, enabling data transfer from these remote analysers for subsequent processing.

TRADING UPDATES: Argo Blockchain, HC Slingsby suffer profit drops

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

EKF Diagnostics making 'good' investment progress

(Sharecast News) - EKF Diagnostics said in an update on Wednesday that it has already made "good progress" with its investment plans to support growth in the new financial year.

UK shareholder meetings calendar - next 7 days

DIRECTOR DEALINGS: EKF, Petershill and Dunelm chairs buy shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

EKF confident even as Covid-related revenues wind down

(Sharecast News) - EKF Diagnostics reported a 25% improvement in revenue in its final results on Tuesday, to £81.8m.

IN BRIEF: EKF Diagnostics profit jumps in 2021 but Covid benefit fades

EKF Diagnostics Holdings PLC - Cardiff-based diagnostics and central laboratory assay maker - Posts improved profit for 2021. Pretax profit rises by 39% to GBP21.4 million from GBP15.4 million in 2020, as revenue grows 25% to GBP81.8 million from GBP65.3 million. Proposes slightly higher dividend of 1.2 pence per share from 1.1p the year before. For the first quarter of 2022, EKF Diagnostics expects a performance in line with 2021. The company sees no benefit from further Covid-related manufacturing and a significant reduction in pandemic-related contracts in 2022.

IN BRIEF: EKF Diagnostics signs partnership with ABEC for US expansion

EKF Diagnostics Holdings PLC - Cardiff-based diagnostics and central laboratory assay maker - Signs partnership agreement with Bethlehem, Pennsylvania-based ABEC Inc, a provider of engineered solutions and services for biotech manufacturing. Agreement provides EKF Life Sciences' South Bend, Indiana facility with customised, large-scale bioprocess equipment and will include a 14,500 litre total volume stainless steel fermenter and an 8,000 litre media preparation system. Says this will enhance EKF's production capacity of enzymes used in a variety of diagnostic and life science applications.

EKF Diagnostics invests another £2.5m in Verici Dx

(Sharecast News) - EKF Diagnostics announced on Monday that it had invested in more than seven million placing shares in Verici Dx, for consideration of £2.5m.

EXECUTIVE CHANGES: Jamie Boot to retire after 40 years with Henry Boot

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

EXECUTIVE CHANGES: Jamie Boot to retire after 40 years with Henry Boot

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

TRADING UPDATES: Cordiant raises GBP200 million; Home REIT spends

TRADING UPDATES: Cordiant raises GBP200 million; Home REIT spends

EKF ends year ahead of already-upgraded expectations

(Sharecast News) - Point-of-care, central laboratory device and chemistry reagent company EKF Diagnostics said on Tuesday that continued strong trading would result in its performance for 2021, including adjusted EBITDA, ahead of already-upgraded market expectations.

Trellus Health appoints EKF Diagnostics operating chief Evans as CFO

Trellus Health appoints EKF Diagnostics operating chief Evans as CFO